New insights into cortisol replacement therapy optimization - our latest publication by Davide Bindellini et al. in July. Model-informed precision dosing for novel and established therapeutic modalities in oncology - invited conference talk by Fenja Klima in September.
Hans Günter Schäfer Science Award 2024 for Yomna Nassar
for “C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling Framework”.
The call for application 2023/24 is now open to start the PharMetrX Research+ Program or the PharMetrX Teaching+ Program with the tailored Module Curriculum in March 2024. Deadline: 15 Sept 2023
Congratulations to PharMetrX program chair Charlotte Kloft and her team
Charlotte Kloft was awarded for her innovative team work on ”Early Survival Prediction Framework in CD19-Specific CAR-T Cell Immunotherapy Using a Quantitative Systems Pharmacology Model“ (in Mueller-Schoell et al. Cancers 2021). Together with colleagues from the MD Andersson Cancer Center in Texas/US, Charité-Universitaetsmedizin Berlin and Wilhelm Huisinga from the Universität Potsdam, she developed with her team a mathematical model to early predict success of the innovative CAR-T cell therapy for the individual patient.
